Tianjing Li, Ph.D.
Affiliations: | 2010 | Johns Hopkins University, Baltimore, MD |
Area:
Epidemiology, Public Health, OphthalmologyGoogle:
"Tianjing Li"Cross-listing: PHTree
Parents
Sign in to add mentor| Kay Dickersin | grad student | 2010 | Johns Hopkins | |
| (Bridging the gap between evidence generation and clinical decision making.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wilkinson J, Heal C, Antoniou GA, et al. (2024) Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. Bmj Open. 14: e084164 |
| Wilkinson J, Heal C, Antoniou GA, et al. (2023) Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. Medrxiv : the Preprint Server For Health Sciences |
| Junqueira DR, Zorzela L, Golder S, et al. (2023) CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials. Journal of Clinical Epidemiology |
| Junqueira DR, Zorzela L, Golder S, et al. (2023) CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials. Bmj (Clinical Research Ed.). 381: e073725 |
| Mayo-Wilson E, Qureshi R, Li T. (2023) Conducting separate reviews of benefits and harms could improve systematic reviews and meta-analyses. Systematic Reviews. 12: 67 |
| Lindsley K, Fusco N, Li T, et al. (2022) Clinical trial registration was associated with lower risk of bias compared with non-registered trials among trials included in systematic reviews. Journal of Clinical Epidemiology |
| Page MJ, McKenzie JE, Bossuyt PM, et al. (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Revista Espanola De Cardiologia (English Ed.). 74: 790-799 |
| Page MJ, McKenzie JE, Bossuyt PM, et al. (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Plos Medicine. 18: e1003583 |
| Williamson PR, de Ávila Oliveira R, Clarke M, et al. (2020) Assessing the relevance and uptake of core outcome sets (an agreed minimum collection of outcomes to measure in research studies) in Cochrane systematic reviews: a review. Bmj Open. 10: e036562 |
| Zeng L, Qureshi R, Viswanathan S, et al. (2020) Registration of phase 3 crossover trials on ClinicalTrials.gov. Trials. 21: 613 |